ATE472528T1 - 2-methylen-18,19-dinor-1alfa-hydroxy- homopregnacalciferol und dessen verwendungen - Google Patents
2-methylen-18,19-dinor-1alfa-hydroxy- homopregnacalciferol und dessen verwendungenInfo
- Publication number
- ATE472528T1 ATE472528T1 AT05848578T AT05848578T ATE472528T1 AT E472528 T1 ATE472528 T1 AT E472528T1 AT 05848578 T AT05848578 T AT 05848578T AT 05848578 T AT05848578 T AT 05848578T AT E472528 T1 ATE472528 T1 AT E472528T1
- Authority
- AT
- Austria
- Prior art keywords
- dinor
- methylene
- skin
- compound
- homopregnacalciferol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 abstract 1
- 206010013786 Dry skin Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 208000037979 autoimmune inflammatory disease Diseases 0.000 abstract 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000037336 dry skin Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 201000006409 renal osteodystrophy Diseases 0.000 abstract 1
- 210000002374 sebum Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63018204P | 2004-11-22 | 2004-11-22 | |
PCT/US2005/042030 WO2006057932A2 (en) | 2004-11-22 | 2005-11-18 | 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE472528T1 true ATE472528T1 (de) | 2010-07-15 |
Family
ID=36215592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05848578T ATE472528T1 (de) | 2004-11-22 | 2005-11-18 | 2-methylen-18,19-dinor-1alfa-hydroxy- homopregnacalciferol und dessen verwendungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7238681B2 (de) |
EP (1) | EP1817278B1 (de) |
JP (1) | JP5043674B2 (de) |
AT (1) | ATE472528T1 (de) |
AU (1) | AU2005309747A1 (de) |
CA (1) | CA2588417C (de) |
DE (1) | DE602005022098D1 (de) |
ES (1) | ES2349662T3 (de) |
MX (1) | MX2007006544A (de) |
NZ (1) | NZ555280A (de) |
WO (1) | WO2006057932A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713951B2 (en) * | 2004-04-09 | 2010-05-11 | Wisconsin Alumni Research Foundation | 2-alkylidene-18,19-dinor-vitamin D compounds |
WO2009116557A1 (ja) * | 2008-03-21 | 2009-09-24 | 富士フイルム株式会社 | 薬剤含有組成物 |
WO2011119610A2 (en) * | 2010-03-23 | 2011-09-29 | Wisconsin Alumni Research Foundation | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3 |
US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
US20110237557A1 (en) * | 2010-03-23 | 2011-09-29 | Deluca Hector F | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
US8420839B1 (en) | 2011-10-05 | 2013-04-16 | Wisconsin Alumni Research Foundation | Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol |
AU2012268858B2 (en) * | 2012-12-21 | 2017-03-09 | Wisconsin Alumni Research Foundation | Crystallization of 1a-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol |
EP2746252A1 (de) | 2012-12-21 | 2014-06-25 | Wisconsin Alumni Research Foundation (WARF) | Kristallisierung von 1alpha-Hydroxy-2-methylen- 18,19-dinor-homopregnacalciferol |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
NZ524657A (en) * | 2000-09-08 | 2004-12-24 | Wisconsin Alumni Res Found | 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
US6627622B2 (en) * | 2002-02-18 | 2003-09-30 | Wisconsin Alumni Research Foundation | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
KR20040095237A (ko) * | 2002-03-29 | 2004-11-12 | 위스콘신 얼럼나이 리서어치 화운데이션 | 1α-히드록시-2-메틸렌-19-노르-호모프레그나칼시페롤의합성 방법 |
US6846811B2 (en) * | 2002-04-22 | 2005-01-25 | Wisconsin Alumni Research Foundation | (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
MXPA06005887A (es) * | 2003-11-25 | 2006-06-27 | Wisconsin Alumni Res Found | Analogos de vitamina d para la prevencion y el tratamiento de la obesidad. |
-
2005
- 2005-11-18 AU AU2005309747A patent/AU2005309747A1/en not_active Abandoned
- 2005-11-18 NZ NZ555280A patent/NZ555280A/en not_active IP Right Cessation
- 2005-11-18 US US11/283,222 patent/US7238681B2/en active Active
- 2005-11-18 CA CA2588417A patent/CA2588417C/en not_active Expired - Fee Related
- 2005-11-18 DE DE602005022098T patent/DE602005022098D1/de active Active
- 2005-11-18 AT AT05848578T patent/ATE472528T1/de not_active IP Right Cessation
- 2005-11-18 ES ES05848578T patent/ES2349662T3/es active Active
- 2005-11-18 MX MX2007006544A patent/MX2007006544A/es active IP Right Grant
- 2005-11-18 EP EP05848578A patent/EP1817278B1/de not_active Not-in-force
- 2005-11-18 WO PCT/US2005/042030 patent/WO2006057932A2/en active Application Filing
- 2005-11-18 JP JP2007543320A patent/JP5043674B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20060122157A1 (en) | 2006-06-08 |
MX2007006544A (es) | 2007-07-25 |
JP2008520716A (ja) | 2008-06-19 |
EP1817278A2 (de) | 2007-08-15 |
WO2006057932A2 (en) | 2006-06-01 |
WO2006057932A3 (en) | 2006-08-03 |
AU2005309747A1 (en) | 2006-06-01 |
EP1817278B1 (de) | 2010-06-30 |
ES2349662T3 (es) | 2011-01-10 |
DE602005022098D1 (de) | 2010-08-12 |
US7238681B2 (en) | 2007-07-03 |
NZ555280A (en) | 2010-12-24 |
CA2588417C (en) | 2012-09-18 |
CA2588417A1 (en) | 2006-06-01 |
JP5043674B2 (ja) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005021245D1 (de) | 2-methylen-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and dessen verwendungen | |
MX2007006263A (es) | Analogos 2a-metil y 2??-metil de 19,26,27-trinor-(20s)-1a- hidroxivitamina d3 y sus usos. | |
DE60215225D1 (de) | Alpha-hydroxy-2-methylen-10-nor-pregnacalciferol und seine anwendungen | |
WO2006057899A3 (en) | 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses | |
PT1315504E (pt) | 1-alfa-hidroxi-2-metileno-19-nor-homopregnacalciferol e suas aplicacoes terapeuticas | |
MX2007006262A (es) | 2-metilen-19-nor-1a-hidroxi-17-en homopregnacalciferol y sus usos. | |
ATE472528T1 (de) | 2-methylen-18,19-dinor-1alfa-hydroxy- homopregnacalciferol und dessen verwendungen | |
MX2009003241A (es) | Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d. | |
ATE552239T1 (de) | 2-methylen-20-methyl-19,24,25,26,27-pentanor- vitamin-d-analoga | |
DE60229430D1 (de) | (20s)-1 alpha-hydroxy-2-methylen-19-nor-bishomopregnacalciferol und ihre verwendungen | |
MX2010007264A (es) | Análogos de vitamina d 2-metilen-(20s, 25r)-19, 26-dinor. | |
ATE552238T1 (de) | 2-methylen-(20s,25s)-19,27-dinor-(22e)-vitamin- - analoga | |
WO2006057902A3 (en) | 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses | |
WO2009086439A3 (en) | 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs | |
ATE496885T1 (de) | 1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor vitamin-d-verbindungen mit einer 1,1- dimethylpropyl-seitenkette |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |